Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral clonidine versus metoclopramide versus placebo before laparoscopic cholecystectomy
IRCT20210919052515N4Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in postoperative nausea and vomiting (PONV) comparing Oral clonidine, Oral metoclopramide and Placebo (3 arms). Primary endpoints: Intraoperative hemodynamic parameters, Nausea and 1 more. Started May 2022; status: completed.
02
Drugs
clonidinemetoclopramide
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20210919052515N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210919052515N4.